9-120821411-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_005047.4(PSMD5):c.1060C>T(p.Pro354Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,609,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_005047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSMD5 | NM_005047.4 | c.1060C>T | p.Pro354Ser | missense_variant | 8/10 | ENST00000210313.8 | NP_005038.1 | |
PSMD5 | NM_001270427.2 | c.931C>T | p.Pro311Ser | missense_variant | 7/9 | NP_001257356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSMD5 | ENST00000210313.8 | c.1060C>T | p.Pro354Ser | missense_variant | 8/10 | 1 | NM_005047.4 | ENSP00000210313.2 | ||
PSMD5 | ENST00000373904.5 | c.931C>T | p.Pro311Ser | missense_variant | 7/9 | 2 | ENSP00000363011.5 | |||
PSMD5 | ENST00000373920.6 | c.79C>T | p.Pro27Ser | missense_variant | 2/4 | 5 | ENSP00000363030.2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152054Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000181 AC: 45AN: 248960Hom.: 0 AF XY: 0.000200 AC XY: 27AN XY: 134754
GnomAD4 exome AF: 0.000162 AC: 236AN: 1457106Hom.: 0 Cov.: 30 AF XY: 0.000188 AC XY: 136AN XY: 724990
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74380
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at